1-832-868-1888

order@swbio.com

Home > products > PRDM1 Antibody

PRDM1 Antibody

Catalog Number:

48403
other_names: B Lymphocyte Induced Maturation Protein 1 antibody
Beta interferon gene positive regulatory domain I binding factor antibody
Beta-interferon gene positive regulatory domain I-binding factor antibody
BLIMP-1 antibody
BLIMP1 antibody
Positive Regulatory Domain I Binding Factor 1 antibody
Positive regulatory domain I-binding factor 1 antibody
PR Domain Containing 1 antibody
PR domain containing 1 with ZNF domain antibody
PR domain containing 1 with ZNF domain isoform 2 antibody
PR domain containing protein 1 antibody
PR domain zinc finger protein 1 antibody
PR domain-containing protein 1 antibody
PRDI BF1 antibody
PRDI binding factor 1 antibody
PRDI-BF1 antibody
PRDI-binding factor 1 antibody
PRDM 1 antibody
Prdm1 antibody
PRDM1_HUMAN antibody

Amount:

100μg
calculated_mw: 92 kDa
host_species: Mouse

Price:

$529

Swiss-Prot No:

Swiss-Prot#:O75626

Form of Antibody:

1*TBS (pH7.4), 1%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide.

Storage/Stability:

Immunogen:

Recombinant protein

Purification:

ProA affinity purified

Specificity/Sensitivity:

Applications:

WB, ICC, FC

Background:

The development and differentiation of plasma cells, which are terminally differentiated B-cells, are induced by Blimp-1 (B lymphocyte-induced maturation protein, also designated PRDI-BF1). Blimp-1 is a transcriptional repressor that localizes to the nucleus and is considered a master regulator of terminal B-cell development. Alone, Blimp-1 is sufficient to trigger terminal B-cell differentiation. Blimp-1 upregulates the expression of syndecan-1 and J chain, represses IFN-b gene transcription and associates with HDAC to recruit it to DNA, thereby repressing c-myc. Blimp-1 is expressed during the late stages of B-cell differentiation in immunoglobulin-secreting plasma cells, as well as in long-lived, bone marrow plasma cells. The expression of Blimp-1 defines a checkpoint beyond which fully activated B cells proceed to the plasma cell stage, whereas immature and partially activated cells are eliminated.

References:

appl_detail:

WB: 1:500-1:2,000

ICC: 1:200-1:1,000

FC: 1:100-1:200

Datasheet PDF

Product Search

CONTACT US

1-832-868-1888 order@swbio.com

GET IN TOUCH

© Signalway Biotechnology All Rights Reserved.
Powered by Signalway | Sitemap